🇺🇸 Intranasal dexmedetomidine in United States

Intranasal dexmedetomidine (Intranasal dexmedetomidine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intranasal dexmedetomidine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intranasal dexmedetomidine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intranasal dexmedetomidine in United States?

Sun Fei is the originator. The local marketing authorisation holder may differ — check the official source linked above.